RCOG/LinkedIn
Oct 13, 2026, 15:41
Cell-Free Fetal DNA Testing for Single-Gene Conditions – RCOG
Royal College of Obstetricians and Gynaecologists (RCOG) shared on LinkedIn:
“We have published a new Scientific Impact Paper on cell-free fetal DNA testing for single-gene conditions (Scientific Impact Paper No. 80).
Cell-free fetal DNA (cffDNA) circulates in a pregnant woman’s blood in early pregnancy and is a potential source of genetic material from the developing fetus that can be used to test the baby for selected genetic conditions.
This opinion paper reviews non-invasive prenatal diagnosis (NIPD) using cffDNA in specific single-gene conditions where it may be offered as an alternative to traditional invasive testing.
Other articles featuring RCOG on Fertility News.
-
Nov 9, 2026, 16:12Göksu Dirgin: Mosaic Embryos – IVF’s Unsolved Riddle
-
Nov 9, 2026, 15:59Robert Gilchrist: Honoured to Present at the 9th International Conference on Human Fertility Protection and Preservation
-
Nov 9, 2026, 15:54Camille Hammond: I Went Through Infertility Treatment While Training to Be a Doctor
-
Nov 9, 2026, 15:49Sean Lauber: Do Zymot or Other Microfluidic Devices Improve IVF Success?
-
Nov 9, 2026, 15:44Clare Mansfield: Transforming Fertility Care So That People Feel Seen, Heard and Supported
-
Nov 9, 2026, 15:37Thanos Papathanasiou: The Effect of Male Smoking on IVF Success
-
Nov 8, 2026, 15:46Finding the Right Doctor When You Have PCOS – PCOS Millennials
-
Nov 8, 2026, 15:35Patrick Gordon: Delighted to Welcome the New Leeds Andrology Fellow, Paul Gravestock
-
Nov 8, 2026, 15:32Kholoud Khaled Al Mahdy: A Wonderful Gathering at Merck’s LH Symphony
